These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35103115)

  • 41. Updates on clinical trials evaluating the regenerative potential of allogenic mesenchymal stem cells in COVID-19.
    Sharma D; Zhao F
    NPJ Regen Med; 2021 Jun; 6(1):37. PubMed ID: 34193864
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mesenchymal stem cells and COVID-19: What they do and what they can do.
    Abu-El-Rub E; Khasawneh RR; Almahasneh F; Altaany Z; Bataineh N; Zegallai H; Sekaran S
    World J Stem Cells; 2021 Sep; 13(9):1318-1337. PubMed ID: 34630865
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Potential roles of mesenchymal stem cells and their exosomes in the treatment of COVID-19.
    Cheng X; Jiang M; Long L; Meng J
    Front Biosci (Landmark Ed); 2021 Oct; 26(10):948-961. PubMed ID: 34719217
    [No Abstract]   [Full Text] [Related]  

  • 44. Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients.
    Al-Khawaga S; Abdelalim EM
    Stem Cell Res Ther; 2020 Oct; 11(1):437. PubMed ID: 33059757
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Current status of mesenchymal stem cell therapy for immune/inflammatory lung disorders: Gleaning insights for possible use in COVID-19.
    Yen BL; Yen ML; Wang LT; Liu KJ; Sytwu HK
    Stem Cells Transl Med; 2020 Oct; 9(10):1163-1173. PubMed ID: 32526079
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Research progress on Mesenchymal Stem Cells (MSCs), Adipose-Derived Mesenchymal Stem Cells (AD-MSCs), Drugs, and Vaccines in Inhibiting COVID-19 Disease.
    Gentile P; Sterodimas A; Pizzicannella J; Calabrese C; Garcovich S
    Aging Dis; 2020 Oct; 11(5):1191-1201. PubMed ID: 33014532
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Are mesenchymal stem cells able to manage cytokine storm in COVID-19 patients? A review of recent studies.
    Kaffash Farkhad N; Reihani H; Sedaghat A; Moghadam AA; Moghadam AB; Tavakol-Afshari J
    Regen Ther; 2021 Dec; 18():152-160. PubMed ID: 34124322
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated with Coronavirus Disease-2019.
    Nagarkatti P; Miranda K; Nagarkatti M
    Front Pharmacol; 2020; 11():589438. PubMed ID: 33240092
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mesenchymal Stem Cells and COVID-19: Cure, Prevention, and Vaccination.
    Afarid M; Sanie-Jahromi F
    Stem Cells Int; 2021; 2021():6666370. PubMed ID: 34035820
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mesenchymal Stem Cells and Their Extracellular Vesicles: A Potential Game Changer for the COVID-19 Crisis.
    Kassem DH; Kamal MM
    Front Cell Dev Biol; 2020; 8():587866. PubMed ID: 33102489
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Stem cell therapy for COVID-19 pneumonia.
    Kebria MM; Milan PB; Peyravian N; Kiani J; Khatibi S; Mozafari M
    Mol Biomed; 2022 Feb; 3(1):6. PubMed ID: 35174448
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mesenchymal stem/stromal cells as adjuvant therapy in COVID-19-associated acute lung injury and cytokine storm: Importance of cell identification.
    Pawitan JA
    World J Stem Cells; 2022 Mar; 14(3):264-266. PubMed ID: 35432737
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regenerative therapy by using mesenchymal stem cells-derived exosomes in COVID-19 treatment. The potential role and underlying mechanisms.
    Kaffash Farkhad N; Mahmoudi A; Mahdipour E
    Regen Ther; 2022 Jun; 20():61-71. PubMed ID: 35340407
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Perinatal Cells: A Promising COVID-19 Therapy?
    Papait A; Cargnoni A; Sheleg M; Silini AR; Kunis G; Ofir R; Parolini O
    Front Bioeng Biotechnol; 2020; 8():619980. PubMed ID: 33520970
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combating COVID-19 with mesenchymal stem cell therapy.
    Rajarshi K; Chatterjee A; Ray S
    Biotechnol Rep (Amst); 2020 Jun; 26():e00467. PubMed ID: 32420049
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunopathology and Immunosenescence, the Immunological Key Words of Severe COVID-19. Is There a Role for Stem Cell Transplantation?
    Ligotti ME; Pojero F; Accardi G; Aiello A; Caruso C; Duro G; Candore G
    Front Cell Dev Biol; 2021; 9():725606. PubMed ID: 34595175
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Host-Based Treatments for Severe COVID-19.
    Mondini L; Salton F; Trotta L; Bozzi C; Pozzan R; Barbieri M; Tavano S; Lerda S; Hughes M; Confalonieri M; Confalonieri P; Ruaro B
    Curr Issues Mol Biol; 2023 Apr; 45(4):3102-3121. PubMed ID: 37185727
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeting mesenchymal stem cell therapy for severe pneumonia patients.
    Lam G; Zhou Y; Wang JX; Tsui YP
    World J Stem Cells; 2021 Feb; 13(2):139-154. PubMed ID: 33708343
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hemophagocytic lymphohistocytosis in a COVID-19 patient in the acute phase: case report.
    Salamoon M; Kenj M
    Memo; 2022; 15(2):149-152. PubMed ID: 34149939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.